D&d Pharmatech

Developer of GLP-1-based therapeutics for metabolic disease treatment

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2014 groups16 employees language ddpharmatech.com

Registered entities

Investor mix

12 investors on record; lead investors include Praxis Capital, Smile Gate Investment; 1 has since exited.

Investor typeCountShare
Venture capital542%
Private equity325%
Bank & private debt18%
Other / undisclosed325%
Coming soon